chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: FLUA3
Symptoms: Injection site pain, Injection site reaction, Rash macular
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713055), concerns a 78-year-old, elderly female patient. The patient was allergic to sulfa drugs, FLAGYL and codeine. On 12-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178301, expiry date: not reported). On the same day, the patient developed red splotch marks down the arm from the injection site to the elbow. It was reported that, those red splotches were painful but did not appear to be a rash. At the time of this report, the patient had not recovered from the events. The reporter considered the case as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Erythema, Haemorrhage subcutaneous
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713118), concerns an 83-year-old, elderly female patient. The patient's current condition included diabetes and concomitant medication included metformin. The patient had no known allergy. On 16-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178602, expiry date: not reported). On 17-Sep-2017, next day of vaccination, the patient developed large red area (approximately 2 inches in diameter) and bleeding underneath skin. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 68.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: This is spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713471), concerns a 68-year-old elderly female patient. The patient's concomitant medication included Atorvastatin. On 11-Sep-2017, the patient received FLUAD vaccine (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: 178323) and PREVNAR 13 (dose: 1 as reported, route of administration: intramuscular, anatomical location: left arm, batch number: R12280). On 15-Sep-2017, 4 days, after vaccine administration, the patient's arm was warm and red on Friday morning. The symptoms got worse overnight and the patient came to pharmacy on Saturday. Her arm was slightly swollen and became red. The patient was suggested to have some ice pack and gave her 3 BENADRYL to take every night for next 3 nights. The patient was suggested to consult physician if the symptoms got worsened. The outcome of all the events was recovered. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713544), concerns a 66-year-old elderly female patient. On 12-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml (unk as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178323). On 12-Sep-2017, the patient was administered with co-suspect PNEUMOVAX (dose: unknown as reported), route of administration: intramuscular, anatomical location: right arm, batch number: N000463 as reported). On 13-Sep-2017, 2 days, after vaccination the patient had shoulder pain which radiated (radiation cross as reported) down the arm. It was reported that, the patient had severe shoulder pain. The health authority provided the PT injection site pain. The outcome of the events was not reported. The reporter assessed the case as non-serious.
Age: 82.0
Sex: F
Vaccine: FLUA3
Symptoms: Injected limb mobility decreased, Injection site hypoaesthesia, Injection site nerve damage, Injection site pain, Mobility decreased
Clinical narrative: This spontaneous case, reported by non-health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713547), concerns 82-year-old elderly female patient. On an unspecified date, the patient underwent pacemaker insertion. The patient's concomitant medication included XARELTO for an unknown indication. On 18-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178901 and expiry date: not reported). On 19-Sep-2017, 1 day after vaccination, the patient had difficulty in moving arms, numbness (some) and sharp pain at the injection site. It was reported that, the patient experienced significant pain all day. The patient went to hospital and was examined by the physician, in physician's opinion vaccine liquid or needle struck nerve was the reason for the cause of pain. The outcome of the events was not recovered. The reporter assessed this case as non-serious.
Age: 82.0
Sex: F
Vaccine: FLUA3
Symptoms: Pain
Clinical narrative: This spontaneous case, reported by non-health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713547), concerns 82-year-old elderly female patient. On an unspecified date, the patient underwent pacemaker insertion. The patient's concomitant medication included XARELTO for an unknown indication. On 18-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178901 and expiry date: not reported). On 19-Sep-2017, 1 day after vaccination, the patient had difficulty in moving arms, numbness (some) and sharp pain at the injection site. It was reported that, the patient experienced significant pain all day. The patient went to hospital and was examined by the physician, in physician's opinion vaccine liquid or needle struck nerve was the reason for the cause of pain. The outcome of the events was not recovered. The reporter assessed this case as non-serious.
Age: 85.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713690), concerning an 85-year-old, adult female patient. The patient's medical history and concomitant medication was not reported. It was reported that, the patient was not allergic to latex. On 13-Sep-2017, the patient received FLUAD (TIV) (dose: 0.5 ml (dose: reported as 1 dose), route of administration: intramuscular, anatomical location: right arm, batch number, expiry date: not reported). On the same day, the patient was administered with non-company suspect drug PNEUMOVAX (dose: 2 DF, route of administration: intramuscular, anatomical location: left arm). On 15-Sep-2017, after 2 days of vaccination, the patient developed redness and warmth. It was reported that swelling was receding but not as bad as day before. The patient was advised with APAP (dose: 325) and diphenhydramine (dose: 25). She was suggested to go to emergency if the condition gets worsened. The outcome of the events was not reported. The reporter assessed this case as non-serious. Non-significant case correction received with IRD 06-Mar-2018: Case comment was amended. No changes were made in the narrative.
Sex: M
Vaccine: FLUA3, TDAP
Symptoms: Injection site erythema, Injection site haemorrhage, Injection site swelling
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713872), concerns a 77-year-old, elderly, male patient. The patient's medical history and concomitant medications were not reported. On 12-Sep-2017, the patient was administered with FLUAD (TIV) (dose:0.5, anatomical location: right arm, batch number: 179002, route of administration: unknown and expiry date: not reported) and ADACEL (anatomical location: left arm, route of administration: unknown, dose, route of administration: unknown, manufacturer, trade name, batch number and expiry date: not reported). On the same day, at the time of vaccination, the patient bled a lot and stated that, his arm was larger than another arm (not at injection site). On 13-Sep-2017, the patient's arm and biceps were swollen and became red. The outcome of the events was not unknown. The reporter considered the case as non-serious.
Age: 71.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site reaction, Injection site warmth, Rash erythematous
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713904), concerns a 71-year-old elderly female patient. On 19-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623, expiry date: not reported). On 20-Sep-2017, 1 day after vaccination, the patient experienced red circular rash approximately 2 inches across about one-half to one inch below injection site which was warm to touch. The outcome of the events was not reported. The reporter assessed this case as non-serious.
Age: 66.0
Sex: M
Vaccine: FLUA3
Symptoms: Cough, Throat tightness
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 By Seqirus from VAERS (VAERS ID: 713954), concerns a 66-year-old, elderly, male patient. The patient's medical history was not reported. The patient had no allergy. The patient's concomitant medications included amlodipine, atorvastatin, benazepril, finasteride, pantoprazole. On 01-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623 and expiry date: not reported). On the same day, shortly after the vaccination, the patient had coughing and little throat tightness. The patient received 2 BENADRYL tablets (25mg) with water and sat down. After some time, his symptoms were improving. After about 25 minutes, the patient felt fine (recovered) from the event and was ready to go home. He was instructed to follow up at an emergency room. The reporter assessed the events as non-serious.
Age: 71.0
Sex: F
Vaccine: FLUA3
Symptoms: Cough, Eye pain, Myalgia, Pyrexia, Rhinorrhoea
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 714280), concerns a 71-year-old, elderly, female patient. The patient had no medical history and allergy. The patient did not received any concomitant medication. On 21-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported). On the same day after the vaccination, the patient had fever, cough, runny nose, muscle aches and sore eyes. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 66.0
Sex: F
Vaccine: FLUA3
Symptoms: Asthenia, Injected limb mobility decreased, Injection site pain, Swelling
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 714286), concerns a 66-year-old elderly female patient. The patient's current conditions included controlled hypertension. It was reported that, the patient was allergic to penicillin. The patient's concomitant medications included potassium, furosemide, lisinopril and multivitamins. On 01-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623, expiry date: not reported). On the same day, 5 hours after the vaccination, the patient experienced swelling, which was not visually seen. On 23-Sep-2017, 22 days after vaccination, the patient experienced weakness, pain (10 on 1-10pain scale) at the injection site and was unable to lift her arm. Her range of motion of the shoulder was limited. It was reported that, the patient can wiggle her fingers and move it, but less than normal. At the time of this report, the outcome of the events was not recovered. The reporter assessed this case as non-serious.
Sex: M
Vaccine: FLUA3
Symptoms: Asthenia, Groin pain, Loss of personal independence in daily activities, Myalgia, Weight bearing difficulty
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 714290), concerns a 65-year-old elderly male patient. On 01-Aug-2017, the patient received FLUAD vaccine (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178601). On 21-Aug-2017, 20 days after vaccination, the patient had debilitating muscle pain in both arms and groin area. It was reported that, the patient was an avid swimmer and could not swim anymore. The patient used to bench press 50 lbs or more, but from then could not even lift 25 lbs. It was stated that, the symptoms started 2 days after receiving flu shot. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious. Non-significant case correction received on 06-Mar-2018: The case comment was corrected by adding 'very plausible temporal relationship between events and suspect vaccine'.
Age: 66.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema, Injection site swelling, Pain in extremity
Clinical narrative: This spontaneous case, reported by other non-healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 714292), concerns a 66-year-old, elderly female patient. The patient's current condition included high blood pressure and no known allergies. The patient's concomitant medications included atenolol, vitamin C, vitamin D, Baby aspirin. On 21-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178901, expiry date: not reported) and PNEUMOVAX (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: N013521, expiry date: not reported). On 22-Sep-2017 (early afternoon), the patient developed significant redness and swelling in right arm. On the same day evening, the patient had sore arm (described as really sore). After the shower, the injected area turned red and was swollen. It was reported that, the area of redness covered most of the upper arm down the area of elbow. The outcome of the events was not reported. The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLUA3
Symptoms: Hypoaesthesia, Pain
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 714301), concerns 83-year-old elderly female patient. The patient's concomitant methocarbamol, donepezil and allopurinol. On 13-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623, expiry date: not reported). On 15-Sep-2017 after 2 days of vaccination, patient felt that vaccine was administered a little hard and began to experience pain and numbness. It was reported that, the patient had completely numbness on his left arm. Patient stated that, he feels that it was due to vaccine administration. It was reported that, the patient was advised to seek the medical attention as the patient was reported his arm was "reported as feeling dead". The outcome of the events was unknown. The reporter assessed this case as non-serious.
Age: 35.0
Sex: F
Vaccine: FLUA3
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: This spontaneous case, reported by 35-year-old, adult female patient to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 714312). The patient's historical condition included, thyroid nodule. The patient was allergic to Sulfa. Concomitant medication included multivitamin for an unknown indication. On 22-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number, expiry date: not reported). On the same day, after vaccination, the patient developed severe numbness and tingling which was worsened in her right hand than left. It disappeared but later the events reappeared in both hands and right foot which lasted for 3 days. It was reported that, the patient would make appointment to her primary care doctor. The patient had not yet recovered from all the events (numbness and tingling). The reporter assessed the events severe numbness and tingling as non-serious.
Age: 82.0
Sex: F
Vaccine: FLUA3
Symptoms: Contusion, Pain, Skin warm, Swelling, Tenderness
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 714588), concerns an 82-year-old, elderly, female patient. The patient had no allergies and no relevant concomitant medications were taken at the time of vaccination. On 23-Nov-2016, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623 and expiry date: not reported). On the same day, after vaccination, at night the symptoms were started with small bruise, swelling, hot to touch and little tenderness. It was reported that, on the left arm bruise started to spread downward, it was still hot to touch, swelling has gone down with not much pain. It was reported that, the patient made her visit to the physician's office. The patient did not receive any treatment for the events and no lab tests was done. At this time of the report, the outcome of all the events was not recovered. The reporter considered the case as non-serious. Non-significant case correction received 06-Mar-2018: Sentence was framed in narrative (from 'patient did not received any treatment' to 'patient did not receive any treatment'. The case comment was corrected by deleting 'systemic immune response' in case comment.
Age: 65.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Arthralgia, Joint swelling, Swollen tongue
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 06-MAR-2018 by Seqirus from VAERS (VAERS ID: 714635), concerns a 65-year-old, elderly, female patient. The patient had no history of allergies. On 16-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5, route of administration: intramuscular, anatomical location: right arm, batch number: 178301 and expiry date: not reported) and PREVNAR 13 (route of administration: intramuscular anatomical location: left arm, dose, manufacturer, trade name, batch number and expiry date: not reported). On 22-Sep-2017, after 6 days of vaccination, the patient stated that, her tongue got swollen and hip was swollen and achy. The patient received BENADRYL and felt better and she did not go to the hospital. At this time of the report, the outcome of the events was recovered. The reporter considered the case as non-serious. Significant case correction received with IRD 06-Mar-2018: The determined causality of the events pain in hip and hip swelling was corrected from related to not related and for the event swollen tongue was corrected from related to unassessable.
Age: 66.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Abdominal discomfort, Asthenia, Contusion, Fatigue, Influenza like illness
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 714803), concerns a 66-year-old, elderly female patient. The patient's historical condition included arthritis and had no current illness at the time of vaccination. On 12-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 2 doses), route of administration: intramuscular, anatomical location: right arm, batch number, expiry date: not reported) and PNEUMOVAX (dose: 2 (as reported), route of administration: intramuscular, anatomical location: right arm, batch number: M040004 (as reported), expiry date: not reported). On 13-Sep-2017, the next day of vaccination, the patient experienced nausea, stomach upset, weakness, fatigue, flu-like illness for 2 to 3 days. The patient also developed bruised and swollen arm for 10 days. The patient had not taken any treatment, but was on rest. On an unspecified date, the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 66.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Nausea, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 714803), concerns a 66-year-old, elderly female patient. The patient's historical condition included arthritis and had no current illness at the time of vaccination. On 12-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 2 doses), route of administration: intramuscular, anatomical location: right arm, batch number, expiry date: not reported) and PNEUMOVAX (dose: 2 (as reported), route of administration: intramuscular, anatomical location: right arm, batch number: M040004 (as reported), expiry date: not reported). On 13-Sep-2017, the next day of vaccination, the patient experienced nausea, stomach upset, weakness, fatigue, flu-like illness for 2 to 3 days. The patient also developed bruised and swollen arm for 10 days. The patient had not taken any treatment, but was on rest. On an unspecified date, the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 73.0
Sex: M
Vaccine: FLUA3
Symptoms: Chest pain, Dyspnoea
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 714811), concerning a 73-year-old, elderly male patient. The patient never had any adverse drug reaction to vaccine before. The patient had no known allergy. The patient's current condition included: hypertension. Concomitant medication included: Lisinopril. On 01-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number: 178623, expiry date: not reported). On the same day, after vaccination, the patient's chest was hurting (chest pain). The patient stated that, he was breathing fine, but his chest was bothering him, and the patient wanted to lie down. The patient sat down near pharmacy. The patient's pain started to get progressively worsened and therefore making it difficult to breathe. Hence, EMS was called. The patient's BP was 110/69 (unit not provided) and pulse rate was 80 (unit not provided). The patient stated that, he felt better when lying on bed. Later, the patient was brought to ER. At the time of this report, the outcome of the events was not unknown. The reporter assessed the events as non-serious. Non-significant case correction received with IRD 06-Mar-2018: The grammatical errors were corrected in narrative. The case comment was updated.
Age: 72.0
Sex: M
Vaccine: FLUA3
Symptoms: Tension headache
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715025), concerning a 72-year-old, elderly male patient. The patient's historical condition included: arrhythmia since an unspecified date. Concomitant medication included: Dofetilide (daily dosage which was unspecified), ZOLOFT, Cinnamon, Multivitamin, Aspirin, plant sterol, PEPCID, unspecified stool softener medication and Omega for an unknown indication. On 25-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number: 179523 (reported as 1795A3), expiry date: not reported). On 26-Sep-2017, after 1 day of vaccination, the patient had tension headache on both sides of head and eyeball level (as reported). The patient had not yet recovered from the event tension headache. The reporter assessed the event as non-serious.
Age: 83.0
Sex: F
Vaccine: FLUA3
Symptoms: Lip swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715081), concerns an 83-year-old, elderly female patient. The patient's historical condition included prediabetes (blood sugar was monitored). The concomitant medications included vitamin D3, TYLENOL, fluocinonide solution for an unknown indications. The patient had no known drug allergies and current illness. On 27-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178302A, expiry date: not reported). On the same day, after vaccination, the patient developed upper lip swelling. The patient had no hives, itching or any other symptoms. The patient was treated with BENADRYL and the event lip swelling resolved within 45 minutes. The outcome of the event lip swelling was recovered. The reporter assessed the case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site erythema, Injection site pain, Injection site reaction, Injection site warmth, Urticaria
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715132), concerns a 65-year-old, elderly, female patient. The patient's medical history, allergy and concomitant medications were not reported. On 17-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, anatomical location: left arm, batch number: 178302A, route of administration and expiry date: not reported). On 18-Sep-2017, after 1 day of vaccination, the patient had injection site redness, pain, warmth and welt. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious. Non-significant case correction received with IRD 06-Mar-2018: The statement in case comment from 'local adverse response' to 'local adverse reaction' was corrected.
Age: 72.0
Sex: F
Vaccine: FLUA3
Symptoms: Headache, Malaise, Myalgia, Neck pain, Pain
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715228), concerns a 72-year-old, elderly, female patient. The patient's current condition included allergic to sulfa drugs, iodine, latex, fish and fish products. The patient's concomitant medication included DEXILANT for an unknown indication. On 28-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178301 and expiry date: not reported). On the same day after 1 hr of vaccination, the patient had severe headache, neck pain, total body pain and severe muscle pain. The patient was sick for 13 days and had a fever of 99.1. The patient described that, pharmacist was not asked about any allergic history to latex or asked whether she wanted the senor dose. It was reported that, the patient thinks that she had an allergic reaction due to latex and reaction to senior dose. At the time of this report, the outcome of the event was not recovered. The reporter assessed the case as non-serious.
Age: 72.0
Sex: F
Vaccine: FLUA3
Symptoms: Pyrexia
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715228), concerns a 72-year-old, elderly, female patient. The patient's current condition included allergic to sulfa drugs, iodine, latex, fish and fish products. The patient's concomitant medication included DEXILANT for an unknown indication. On 28-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178301 and expiry date: not reported). On the same day after 1 hr of vaccination, the patient had severe headache, neck pain, total body pain and severe muscle pain. The patient was sick for 13 days and had a fever of 99.1. The patient described that, pharmacist was not asked about any allergic history to latex or asked whether she wanted the senor dose. It was reported that, the patient thinks that she had an allergic reaction due to latex and reaction to senior dose. At the time of this report, the outcome of the event was not recovered. The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLU3
Symptoms: Chest pain, Cough, Epistaxis, Headache, Lacrimation increased
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715246), concerns a 70-year-old, elderly male patient. The patient had no medical history, current conditions, lab data or known allergies. The concomitant medications included Lisinopril, rosuvastatin calcium, Naproxen, garlic tablets, bee pollen tablets, Multivitamins, lysine, B-12, OCUVITE, ST. JOHN'S WORT for unknown indications. On 01-Sep-2017, the patient was administered with AFLURIA (TIV) (dose:0.5 ml, batch number:XT30006, route of administration, anatomical location, expiry date: not reported). On 22-Sep-2017, after 21 days of vaccination, the patient developed sore throat, cold, nasal condition, wet eyes, headaches, heavy cough, congestion in lungs, chest pain during cough, nose bleed (morning). It was reported that, the patient was improving (on day 8). The patient had cough and light nasal drip. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLU3
Symptoms: Nasal disorder, Nasopharyngitis, Oropharyngeal pain, Pulmonary congestion, Upper-airway cough syndrome
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715246), concerns a 70-year-old, elderly male patient. The patient had no medical history, current conditions, lab data or known allergies. The concomitant medications included Lisinopril, rosuvastatin calcium, Naproxen, garlic tablets, bee pollen tablets, Multivitamins, lysine, B-12, OCUVITE, ST. JOHN'S WORT for unknown indications. On 01-Sep-2017, the patient was administered with AFLURIA (TIV) (dose:0.5 ml, batch number:XT30006, route of administration, anatomical location, expiry date: not reported). On 22-Sep-2017, after 21 days of vaccination, the patient developed sore throat, cold, nasal condition, wet eyes, headaches, heavy cough, congestion in lungs, chest pain during cough, nose bleed (morning). It was reported that, the patient was improving (on day 8). The patient had cough and light nasal drip. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 77.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Feeling hot, Pain, Swelling
Clinical narrative: This spontaneous case, reported by other  health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 7153-7), concerning a 77-year-old, elderly female patient. The patient had no relevant medical history and concomitant medications administered. On 01-Sep-2017, the patient was administered with  FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number, expiry date: not reported). On the same day, the patient was administered with non-company suspect drug PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, batch number, expiry date: not reported). On the same day, after vaccination, the patient experienced redness, heat, pain and swelling. The patient had recovered from all the events. The reporter assessed the events as non-serious. Non-significant case correction received 06-Mar-2018: The case comment was corrected (added co-suspect).
Age: 86.0
Sex: F
Vaccine: FLUA3
Symptoms: Blister, Peripheral swelling, Rash
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715331), concerns 86-year-old elderly female patient. The patient's concomitant medication included aspirin for an unknown indication. On 26-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178623 and expiry date: not reported). On the same day, after the administration of vaccine, the patient developed rash with blister. It was reported that, the patient's arm was swollen. At the time of this report, the outcome of the events was unknown. The reporter assessed this case as non-serious.
Age: 74.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715338), concerns a 74-year-old, elderly male patient. The patient had no known allergies and concomitant medications included omeprazole, levothyroxine, triamterene hydrochlorothiazide, CARTIA XT, pravastatin for unknown indications. On 26-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179301, expiry date: not reported) and PNEUMOVAX (dose: 1 DF (as reported), route of administration: intramuscular, anatomical location: left arm, batch number: N013541, expiry date: not reported). On 27-Sep-2017 (at night) (next day of vaccination), the patient developed redness and swelling in the left arm. It was reported that, the patient had redness over the entire upper arm. At the time of this report, the outcome of the events was not reported. The reporter considered the case as non-serious. Non-significant case correction received with IRD 06-Mar-2018: Case comment was corrected.
Age: 81.0
Sex: F
Vaccine: FLUA3, IPV
Symptoms: Feeding disorder, Feeling hot, Gait disturbance, Loss of personal independence in daily activities, Mobility decreased
Clinical narrative: This spontaneous case, reported by non-health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715380), concerns a 81-year-old, elderly, female patient. The patient's history included flu shot every year and didn't experienced any reaction. The current condition included mild blood pressure and reported that, no known allergies. The concomitant medications included Enalapril, Aspirin, Latanoprost, Acidophilus, B complex, Lecithin, Potassium, Magnesium, Zinc, fish oil, ginkgo biloba, glucosamine for an unknown indication (on an unspecified date). It was reported that, the patient suggested to take vitamins. On 25-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 179203 and expiry date: not reported). On the same day, the patient was administered with non-company suspect product, Polio vaccine (dose, route of administration, anatomical location, batch number, expiry date: not reported). On 26-Sep-2017, after 2 days of vaccination, the patient was unable to move. She ached all over, got out of bed with great difficulty, also had unsteady walking. The patient not able to do usual activities or eat and found difficult to lower herself and found relief by laying down on bed or napping for next 24 hours. It was reported that, the patient seemed to be heated internally and her breath came up very hot. The next morning, the patient had lost two pounds of weight and reported that, in every way she felt energetic and back to normal, taking usual exercise and walking. No lab tests were done to the patient. At the time of the report, the patient had recovered from the events (feeding disorder, mobility decreased, generalised aching, unsteady gait, loss of personal independence in daily activities, feeling hot and lost weight). The reporter assessed the case as non-serious.
Age: 81.0
Sex: F
Vaccine: FLUA3, IPV
Symptoms: Pain, Weight decreased
Clinical narrative: This spontaneous case, reported by non-health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715380), concerns a 81-year-old, elderly, female patient. The patient's history included flu shot every year and didn't experienced any reaction. The current condition included mild blood pressure and reported that, no known allergies. The concomitant medications included Enalapril, Aspirin, Latanoprost, Acidophilus, B complex, Lecithin, Potassium, Magnesium, Zinc, fish oil, ginkgo biloba, glucosamine for an unknown indication (on an unspecified date). It was reported that, the patient suggested to take vitamins. On 25-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 179203 and expiry date: not reported). On the same day, the patient was administered with non-company suspect product, Polio vaccine (dose, route of administration, anatomical location, batch number, expiry date: not reported). On 26-Sep-2017, after 2 days of vaccination, the patient was unable to move. She ached all over, got out of bed with great difficulty, also had unsteady walking. The patient not able to do usual activities or eat and found difficult to lower herself and found relief by laying down on bed or napping for next 24 hours. It was reported that, the patient seemed to be heated internally and her breath came up very hot. The next morning, the patient had lost two pounds of weight and reported that, in every way she felt energetic and back to normal, taking usual exercise and walking. No lab tests were done to the patient. At the time of the report, the patient had recovered from the events (feeding disorder, mobility decreased, generalised aching, unsteady gait, loss of personal independence in daily activities, feeling hot and lost weight). The reporter assessed the case as non-serious.
Age: 86.0
Sex: F
Vaccine: FLUA3
Symptoms: Erythema, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715397), concerns 86-year-old elderly female patient. On 19-Sep-2017, the patient was administered with FLUAD (dose: 0.5ml (unk as reported), route of administration: intramuscular, anatomical location: right arm, batch number: not reported). It was reported that, 5 days later after receiving FLUAD, the patient returned before 4 weeks interim, and requested to administer PNEUMOVAX 23 in the same arm (dose, route of administration, batch number was not reported, anatomical location: right arm). A day after receiving PNEUMOVAX 23, the patient's arm became red, swollen, hot and tender. It was reported that, all the events occurred due to pneumonia shot down to just below the elbow (as reported). Ultrasound at the doctor's office revealed a blood clot, unsure of length. The outcome of the events was recovered. The reporter assessed the case as non-serious.
Age: 86.0
Sex: F
Vaccine: FLUA3
Symptoms: Peripheral swelling, Skin warm, Tenderness, Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715397), concerns 86-year-old elderly female patient. On 19-Sep-2017, the patient was administered with FLUAD (dose: 0.5ml (unk as reported), route of administration: intramuscular, anatomical location: right arm, batch number: not reported). It was reported that, 5 days later after receiving FLUAD, the patient returned before 4 weeks interim, and requested to administer PNEUMOVAX 23 in the same arm (dose, route of administration, batch number was not reported, anatomical location: right arm). A day after receiving PNEUMOVAX 23, the patient's arm became red, swollen, hot and tender. It was reported that, all the events occurred due to pneumonia shot down to just below the elbow (as reported). Ultrasound at the doctor's office revealed a blood clot, unsure of length. The outcome of the events was recovered. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Back pain, Chest discomfort, Erythema, Feeling hot, Flushing
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715515), concerning a 69-year-old, elderly female patient. The patient was allergic to ciprofloxacin (reported as CIPRO). The patient's concomitant medication included levothyroxine and simvastatin. On 01-Sep-2017, the patient received FLUAD (TIV) (dose: 0.5 ml, route of administration, anatomical location, batch number and expiry date: not reported). On the same day, one or two minutes after the shot, the patient felt hot and flushed. Her face and chest were bright red, and she felt vice-like grip on her chest. As the patient sat down, she felt the vice-like grip in her lower back, that was hurting and made her stand. These symptoms were disappeared within few minutes, since then the patient felt shaky. The patient had recovered from the events back pain, chest discomfort, erythema, feeling hot, flushing, muscle tightness and nervousness. The reporter assessed this case as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Muscle tightness, Nervousness
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715515), concerning a 69-year-old, elderly female patient. The patient was allergic to ciprofloxacin (reported as CIPRO). The patient's concomitant medication included levothyroxine and simvastatin. On 01-Sep-2017, the patient received FLUAD (TIV) (dose: 0.5 ml, route of administration, anatomical location, batch number and expiry date: not reported). On the same day, one or two minutes after the shot, the patient felt hot and flushed. Her face and chest were bright red, and she felt vice-like grip on her chest. As the patient sat down, she felt the vice-like grip in her lower back, that was hurting and made her stand. These symptoms were disappeared within few minutes, since then the patient felt shaky. The patient had recovered from the events back pain, chest discomfort, erythema, feeling hot, flushing, muscle tightness and nervousness. The reporter assessed this case as non-serious.
Age: 86.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Dizziness, Flushing
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715518), concerns 86-year-old elderly female patient. On 29-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178301 and expiry date: not reported) and was also administered with PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, dose: (reported as 2), batch number: N013541 and expiry date: not reported). On the same day of vaccination, the patient felt light headed and flushing. The patient was advised to sit down and asked if she had any trouble breathing. Within 10 minutes, flushing and light headedness was subsided, and patient began to feel better. At the time of this report, the outcome of the events had recovered. The reporter assessed this case as non-serious. Non-significant case correction received with the IRD 06-Mar-2018: The co-suspect was added in the case comment.
Age: 76.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site indentation
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-MAR-2018 by Seqirus from VAERS (VAERS) ID: 715615), concerns a 76-year-old, elderly female patient. The patient's historical conditions included COPD, anxiety, hypertension, depression and had no known drug allergy. The patient's concomitant medications included BREO, simvastatin, levothyroxine, raloxifene, lisinopril, lorazepam, bupropion, sertraline. On 01-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number: 178301, expiry date: not reported). On 01-Sep-2017, after 1 month 1 day of vaccination, the patient developed cosmetic, superficial indentation in anterior deltoid area near to site of vaccination. On an unspecified date, the patient had recovered from the event skin indentation. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 06-MAR-2018 by Seqirus from VAERS (VAERS ID: 715627), concerns a 74-year-old, elderly, female patient. The patient's medical history and concomitant medications were not reported. The patient's current condition included allergic to penicillin. On 29-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5, route of administration: intramuscular, anatomical location: left arm, batch number: 179302 and expiry date: not reported). On 30-Sep-2017, after 1 day of vaccination, the patient had redness, heat and swelling at the injection site. The patient was admitted to emergency room (ER) and received with Cephalexin and steroid dose pack. The reporter considered the case as non-serious.
Age: 69.0
Sex: F
Vaccine: FLUA3, VARZOS
Symptoms: Erythema, Pruritus, Rash, Urticaria
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2017 by Seqirus from VAERS (VAERS ID: 715828), concerns a 69-year-old, elderly, female patient. The patient's historical condition, allergy and concomitant medication were not reported. The patient had not any current condition. On 13-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178901 and expiry date: not reported) and non-company suspect product ZOSTAVAX (dose: 1 DF, route of administration: subcutaneous, anatomical location: right arm, batch number: M044220 and expiry date: not reported). On 16-Sep-2017, after 03 days of vaccination, the patient presented with red, itchy hands/palms, non-itchy welts on torso (6-10 up to 3/4 inches in diameter) and rash. There were no SOB (shortness of breath) and injection site redness. The patient used calamine lotion. The patient was suggested to use BENADRYL cream and seek medical attention, if SOB, swelling or difficulty in swallowing experienced. After about 02 hours (as reported), the patient recovered from all the events. The reporter assessed the events as non-serious.